Aveanna Healthcare (AVAH) CAO sells 50K shares in 15M-share offering

Rhea-AI Filing Summary

Aveanna Healthcare Holdings, Inc. (AVAH) reports that Chief Administrative Officer Edwin C. Reisz sold 50,000 shares of common stock on August 20, 2026 at $11.50 per share. The shares were sold as part of an underwritten secondary offering of 15,000,000 shares of Aveanna common stock that closed on August 24, 2026. After this sale, Reisz beneficially holds 1,397,897 shares, which includes 840 shares acquired under the company’s Employee Stock Purchase Plan in June 2026.

Insider Trade Summary

Net Seller: 50,000 shares

Net Sell 1 txn

Insider Reisz Edwin C.

Role Chief Administrative Officer

Sold 50,000 shs ($575K)

Type	Security	Shares	Price	Value
Sale	Common Stock, par value $0.01 per share F1, F2	50,000	$11.50	$575K

Holdings After Transaction: Common Stock, par value $0.01 per share — 1,397,897 shares (Direct)

Footnotes (2)

1. F1. Shares sold by the reporting person were part of an undewritten secondary offering of 15,000,000 shares of the Issuer's common stock which closed on August 24, 2026.
2. F2. Includes 840 shares acquired under the Registrant's Employee Stock Purchase Plan (the "ESPP") in June 2026.

Key Figures

Shares sold: 50,000 shares Sale price per share: $11.50 per share Shares held after transaction: 1,397,897 shares +2 more

5 metrics

Shares sold 50,000 shares Common stock sale by Chief Administrative Officer on August 20, 2026

Sale price per share $11.50 per share Price for the 50,000 Aveanna common shares sold by Edwin C. Reisz

Shares held after transaction 1,397,897 shares Total Aveanna common shares beneficially owned by Edwin C. Reisz after the sale

ESPP shares included in holdings 840 shares Shares acquired under the Employee Stock Purchase Plan in June 2026 included in post-transaction holdings

Secondary offering size 15,000,000 shares Underwritten secondary offering of Aveanna common stock that included Reisz’s sale and closed August 24, 2026

Key Terms

underwritten secondary offering, Employee Stock Purchase Plan, par value

3 terms

underwritten secondary offering financial

"were part of an undewritten secondary offering of 15,000,000 shares"

An underwritten secondary offering is when existing shareholders sell a block of already-issued shares and an investment bank agrees to buy and resell them to the public, guaranteeing the sale will go through. Think of it as a store owner pre-selling a large shipment to a wholesaler who then sells it to customers; for investors, it can increase the number of shares available, affect short-term price pressure, and signal that insiders are taking profits or diversifying holdings.

Employee Stock Purchase Plan financial

"Includes 840 shares acquired under the Registrant's Employee Stock Purchase Plan"

An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

par value financial

"Common Stock, par value $0.01 per share"

Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.

FAQ

What insider transaction did Aveanna Healthcare (AVAH) disclose for Edwin C. Reisz?

Aveanna Healthcare disclosed that Chief Administrative Officer Edwin C. Reisz sold 50,000 shares of common stock on August 20, 2026 in a sale coded "S" (sale in open market or private transaction) at a price of $11.50 per share.

How many Aveanna (AVAH) shares does Edwin C. Reisz hold after the reported sale?

After the reported sale, Edwin C. Reisz beneficially holds 1,397,897 shares of Aveanna common stock. This amount includes 840 shares that were acquired under the company’s Employee Stock Purchase Plan in June 2026.

Was the Edwin C. Reisz sale part of a larger Aveanna (AVAH) offering?

Yes. The filing states that the 50,000 shares sold by Edwin C. Reisz were part of an underwritten secondary offering of 15,000,000 shares of Aveanna common stock, which closed on August 24, 2026.

At what price did Edwin C. Reisz sell Aveanna (AVAH) shares?

The reported transaction shows that Edwin C. Reisz sold 50,000 shares of Aveanna common stock at a price of $11.50 per share on August 20, 2026, as part of a broader underwritten secondary offering.

Were the Aveanna (AVAH) insider sales made under a Rule 10b5-1 trading plan?

No. The Form 4 indicates the Rule 10b5-1 checkbox is not checked, and there is no footnote stating that the 50,000-share sale by Edwin C. Reisz was made pursuant to a Rule 10b5-1 trading plan.

What role does Edwin C. Reisz hold at Aveanna Healthcare (AVAH)?

Edwin C. Reisz is identified in the filing as an officer of Aveanna Healthcare Holdings, Inc., serving as the company’s Chief Administrative Officer in connection with the reported Form 4 insider transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/24/2026 - 04:31 PM Accepted by SEC EDGAR 08/24/2026 - 04:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Reisz Edwin C.

(Last) (First) (Middle)

C/O AVEANNA HEALTHCARE HOLDINGS INC.

400 INTERSTATE NORTH PARKWAY SE

(Street)

ATLANTA GEORGIA 30339

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Aveanna Healthcare Holdings, Inc. [ AVAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Administrative Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	08/20/2026		S		50,000(1)	D	$11.5	1,397,897(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares sold by the reporting person were part of an undewritten secondary offering of 15,000,000 shares of the Issuer's common stock which closed on August 24, 2026.

2. Includes 840 shares acquired under the Registrant's Employee Stock Purchase Plan (the "ESPP") in June 2026.

	/s/ Jonathan Beckler, Attorney-in-Fact	08/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)